We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

deListed Australia



Browse Australian delisted companies0-9A BC DE F GH IJ KL MN OP QR ST UV WX YZ
Browse terminated Australian managed funds0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ


Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:


Delisted from ASX 18/09/2009

Former (or subsequent) names

Shareholder links

Our website ranking of STC: rating 1
(1 out of 5)


Company details

Address: 2nd Floor, Building 75, Monash STRIP,Monash Uni, ClaytonCampus, Wellington Rd,CLAYTON,VIC,AUSTRALIA,3800
Tel:  (03) 9905 0600 Fax: (03) 9905 0611

Date first listed: 16/04/2007
Company Secretary: Mr Paul Bello (Joint Co. Secretary) Mr Giorgio Reggiani (Joint Co. Secretary)
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: tem cell research and development.
delisted at entity's request18/09/2009
company gives notice that "its Shares will be cancelled from admission to, and trading on, the ASX" as from 18 September - rather curious as we thought the shares had not been trading since November last year!16/09/2009
Company says it will keep shareholders informed through its website www.assetrealco.com16/09/2009
company informs CDI holders that it proposes to delist from trading on and admission to, the Australian Securities Exchange ("ASX"). Accordingly it will no longer be necessary or permissible, for interests in the Company's ordinary shares of 1 pence each ("Ordinary Shares"), to be held in the form of Chess Depository Interests ("DIs")14/09/2009
the Company gives notice that subject to confirmation from the ASX, it's Shares will be cancelled from admission to and trading on the ASX at a date to be confirmed by the ASX14/09/2009
further to the announcement made by the Company on 1 June 2009, the Company gives notice that , subject to confirmation from the ASX, its shares (CDI's) will be cancelled from admission to and trading on ASX with effect from close of trading on 1 July 2009 (the "ancellation"). As set out in the circular to shareholders dated 3 March 2009, the Directors intend to re-register the Company as a private limited Company following the Cancellation. The Directors will continue to keep shareholders informed as appropriate, in particular with respect to any subsequent distribution to be made by the Company to its shareholders, through the Company's website26/06/2009
we understand that the company will not be distributing any return of capital before the end of June 2009 as it will "still be involved in the administrative process of delisting and preparing to make the return of capital in a way that ensures the tax authorities view this as a capital loss rather than income gain"22/06/2009
Company gives notice that it's Ordinary Shares will be cancelled from admission to and trading on AIM with effect from 7.00 a.m. on 26 June 200912/06/2009
name changed from Stem Cell Sciences PLC08/04/2009

ASX Announcements (courtesy of ASX)


Your comments

Please read our Terms before viewing comments.


Company Updates

Post your comments here

Please read our Terms before posting comments.
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)


    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    David DoddChairman
    Alastair RiddellCEO, Executive Director
    Giorgio ReggianiFinance Director
    Mike DexterNon Exec Director
    Harry KarelisNon Exec Director
    Peter MountfordNon Exec Director
    Leslie WebbNon Exec Director

    Date of first appointment, title may have changed.

    Directors & Executives (former)


    Date of first appointment, title may have changed.